Lyell Immunopharma (LYEL) Operating Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Lyell Immunopharma | 373.31 Mn | 373.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.57 Mn |
| Dec 31, 2025 | -187.90 Mn |
| Sep 30, 2025 | 34.09 Mn |
| Jun 30, 2025 | 23.03 Mn |
| Mar 31, 2025 | 100.91 Mn |
| Dec 31, 2024 | -168.01 Mn |
| Sep 30, 2024 | 24.78 Mn |
| Jun 30, 2024 | 145.61 Mn |
| Mar 31, 2024 | -139.47 Mn |
| Dec 31, 2023 | -22.16 Mn |
| Sep 30, 2023 | 793,659.00 |
| Jun 30, 2023 | -14.79 Mn |
| Mar 31, 2023 | -9.62 Mn |
| Dec 31, 2022 | 221.45 Mn |
| Sep 30, 2022 | -221.45 Mn |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | -1.07 Mn |
| Dec 31, 2021 | 9,988.00 |
| Sep 30, 2021 | 60,168.00 |
| Jun 30, 2021 | -12,149.00 |
| Mar 31, 2021 | -55,511.00 |
| Dec 31, 2020 | 173,376.00 |
| Sep 30, 2020 | -15,379.00 |